As Afghanistan strives to move towards stability and peactheaftermath of a long conflict, it offers infinite and unprecedented opportunities, inter alia, for (international) businesses as well as individuals. New venues of investment are opening up in almost every sphere of life. The country is being reconnected to the world through its neighbors, some of the world’s biggest untapped mining sites are being revitalized, many miles of roads and railway networks are being developed, and the infrastructure needed to support a modern economy is being put in place.
All these indicate a fresh life coming into a troubled economy and untapped resources Afghanistan offers the world. However, no opportunity come without challenges. The country is new to the fast operating business world, and thus the pre-2001 experiences and systems undermine efficiency of its response to the paceof business.
Hatam & Nouri LLC (H&N) as a full service law firm offers governments, diplomatic missions, local and international companies and individuals the expertise they need to navigate the above mentioned challenges of Afghanistan’s legal and regulatory system and assists them to achieve their business objectives in an effective and efficient manner.
H&N advises domestic and international clients in the private and public sector on a wide array of industries. Clients get the best resultsbecause H&N has a solidgrounding in the region’s languages, cultures, laws and business processes. Our on-the-ground team has sophisticated capabilities and a wide range of expertise to meet the legal and regulatory challenges Afghanistan throws up, to contribute to the success of your business.
By virtue of its expertise and in-depth understanding of the Afghan market, H&N has attained a reputable position in corporate registration, corporate restructuring, trade, employment, taxation, project finance, Public-Private Partnerships, energy sector, infrastructure projects, intellectual property, non-profit and social sector development, telecommunication, construction, pharmaceutical industry, and regulatory affairs.